Frazier Life Sciences Management, L.P. Oric Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q1 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 4,142,855 shares of ORIC stock, worth $29.3 Million. This represents 2.99% of its overall portfolio holdings.
Number of Shares
4,142,855
Previous 2,142,855
93.33%
Holding current value
$29.3 Million
Previous $19.7 Million
188.95%
% of portfolio
2.99%
Previous 1.21%
Shares
2 transactions
Others Institutions Holding ORIC
# of Institutions
113Shares Held
59.3MCall Options Held
302KPut Options Held
7.7K-
Nextech Invest Ag5.29MShares$37.4 Million13.59% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$31.1 Million5.19% of portfolio
-
Viking Global Investors LP4MShares$28.3 Million0.21% of portfolio
-
Alkeon Capital Management LLC New York, NY3.7MShares$26.2 Million0.09% of portfolio
-
Column Group LLC San Francisco, CA3.54MShares$25 Million30.34% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $280M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...